Steroid hormones regulate cell proliferation. Sex steroid stimulate proliferation of epithelial cells of the breast, uterus, vagina, and prostate: whereas glucocorticoids inhibit proliferation of cells of connective tissue origin including keratinocytes, fibroblasts, and lymphocytes. The mitotic effects of steroids appear to be due to regulation of genes whose products are required for progression through the G1 phase of the cell cycle. This proposal focus upon glucocorticoid inhibition of lymphoid cell proliferation, which is associated with Go arrest. Both normal and malignant lymphoid cells undergo Go arrest ina the presence of glucocorticoids, and steroids of this class are routinely used in the treatment of both malignant and nonmalignant lymphoproliferative disorders. Malignant transformation of lymphoid cells may be associated with expression of cell cycle progression factors that are not regulated by glucocorticoids (e.g. Bcll) Our long term objective is to identify the genes that account for Go arrest and to elucidate the molecular mechanisms that account for their regulation by glucocorticoids. We have shown that there are two target genes that account for Go arrest. c-myc and the cyclin D3 gene (CcnD3). This project focuses upon the mechanisms that underlie glucocorticoid inhibition of cyclin D3 expression. The effect is rapid and large: CcnD3 mRNA abundance decreases by 80-90% within 4-5 hr after addition of dexamethasone to mid log phase T lymphoma cells. There is no change in CcnD3 transcription during this time frame. We have determined the CcnD3 mRNA is very stable in control cells, with a half life in excess of 8 hr. Within 2 hr after addition of dexamethasone, the T12 of degradation decreases to 60-90 min. This response requires de novo RNA synthesis. Moreover, deletion of the 3' untranslated region of CcnD3 mRNA blocks the response. We propose that glucocorticoids activate a factor that interacts, directly or indirectly, with the 3' untranslated region of CcnD3 mRNA and increases the rate of degradation of that messenger.
Eight specific aims are proposed to test predictions that emmanate from this working hypothesis.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA024347-21
Application #
2894502
Study Section
Endocrinology Study Section (END)
Program Officer
Mccarthy, Susan A
Project Start
1987-08-01
Project End
2000-06-30
Budget Start
1999-05-01
Budget End
2000-06-30
Support Year
21
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Texas Medical Br Galveston
Department
Biochemistry
Type
Schools of Medicine
DUNS #
041367053
City
Galveston
State
TX
Country
United States
Zip Code
77555
Cao, Yanna; Chen, Lu; Zhang, Weili et al. (2007) Identification of apoptotic genes mediating TGF-beta/Smad3-induced cell death in intestinal epithelial cells using a genomic approach. Am J Physiol Gastrointest Liver Physiol 292:G28-38
Chen, Lu; Necela, Brian M; Su, Weidong et al. (2006) Peroxisome proliferator-activated receptor gamma promotes epithelial to mesenchymal transformation by Rho GTPase-dependent activation of ERK1/2. J Biol Chem 281:24575-87
Chen, Lu; Bush, Craig R; Necela, Brian M et al. (2006) RS5444, a novel PPARgamma agonist, regulates aspects of the differentiated phenotype in nontransformed intestinal epithelial cells. Mol Cell Endocrinol 251:17-32
Chen, Lu; Finnerty, Celeste; Gustafson, William C et al. (2003) Genomic analysis of glucocorticoid-regulated promoters in murine T-lymphoma cells. Recent Prog Horm Res 58:155-74
Murray, Nicole R; Weems, Capella; Chen, Lu et al. (2002) Protein kinase C betaII and TGFbetaRII in omega-3 fatty acid-mediated inhibition of colon carcinogenesis. J Cell Biol 157:915-20
Ma, T; Copland, J A; Brasier, A R et al. (2000) A novel glucocorticoid receptor binding element within the murine c-myc promoter. Mol Endocrinol 14:1377-86
Bresnahan, W A; Albrecht, T; Thompson, E A (1998) The cyclin E promoter is activated by human cytomegalovirus 86-kDa immediate early protein. J Biol Chem 273:22075-82
Bresnahan, W A; Thompson, E A; Albrecht, T (1997) Human cytomegalovirus infection results in altered Cdk2 subcellular localization. J Gen Virol 78 ( Pt 8):1993-7
Bresnahan, W A; Boldogh, I; Chi, P et al. (1997) Inhibition of cellular Cdk2 activity blocks human cytomegalovirus replication. Virology 231:239-47
Bresnahan, W A; Boldogh, I; Ma, T et al. (1996) Cyclin E/Cdk2 activity is controlled by different mechanisms in the G0 and G1 phases of the cell cycle. Cell Growth Differ 7:1283-90

Showing the most recent 10 out of 25 publications